FeesSafety
Pluang+

Kraken enables USDG stablecoin deposits and withdrawals on Arbitrum One for easier funding.

Market News
09 Nov 2026, 08:00 WIB
NewsBTC
View Source
Neutral
Kraken enables USDG stablecoin deposits and withdrawals on Arbitrum One for easier funding.

Kraken has introduced native USDG stablecoin deposits and withdrawals on the Arbitrum One network as of October 29. This update allows users to fund their accounts more conveniently using USDG on Arbitrum One, expanding access to this stablecoin. The move supports smoother transactions and trading for users dealing with USDG on this popular layer-2 scaling solution. It reflects Kraken's effort to enhance user experience by integrating more blockchain networks for stablecoin transfers.

The news about Bitget launching an Open Custody Network is presented here with Pluang's cryptocurrency market data for context. For readers following major cryptocurrencies on Pluang as of Nov 09, 2026 12:41 WIB, only 7 of 50 priced cryptocurrencies rose while 42 fell. Ethereum (ETH) traded at Rp38.492.605 with a 4.85% decline and a typical hold time of 108 days, contrasting with Filecoin (FIL) at Rp13.633, down 3.95%, but with a much higher sell order activity of 84%. Synthetix (SNX) also fell 4.00% to Rp2.857, with a shorter hold time of 71 days and a buy order activity of 66%.

More News

XRP plunges nearly 8% against Bitcoin amid crypto market crash and Nvidia scandal.

XRP plunges nearly 8% against Bitcoin amid crypto market crash and Nvidia scandal.

XRP has sharply declined against Bitcoin, losing nearly 8% of its value over the past week amid a broader cryptocurrency market downturn. The coin dropped 4.9% in the last 24 hours and is currently priced around $1.10. This decline is more severe tha...

Market News
Bearish
5 hours ago
argenx to acquire Unnatural Products for up to $1.15B to boost drug discovery with macrocyclic peptides

argenx to acquire Unnatural Products for up to $1.15B to boost drug discovery with macrocyclic peptides

argenx will acquire Unnatural Products (UNP) for $550 million upfront plus up to $600 million in milestones, totaling about $1.15 billion. UNP specializes in orally-delivered macrocyclic peptides targeting previously undruggable diseases, enhancing a...

Company Fundamentals
Bullish
5 hours ago
Dapirolizumab pegol shows higher response rates and sustained remission in SLE patients versus placebo in Phase 3 trial.

Dapirolizumab pegol shows higher response rates and sustained remission in SLE patients versus placebo in Phase 3 trial.

Dapirolizumab pegol (DZP), an investigational biologic for systemic lupus erythematosus (SLE), demonstrated greater treatment response rates compared to placebo when combined with standard care in the Phase 3 PHOENYCS GO trial. Using a novel Treatmen...

Market News
Bullish
5 hours ago
Valneva reports positive Phase 2 results for its tetravalent Shigella vaccine candidate showing safety and efficacy.

Valneva reports positive Phase 2 results for its tetravalent Shigella vaccine candidate showing safety and efficacy.

Valneva announced positive Phase 2 trial results for its tetravalent Shigella vaccine candidate S4V2, showing a favorable safety profile and encouraging immune responses in infants and adults. The infant trial in Kenya demonstrated significant antibo...

Company Fundamentals
Bullish
5 hours ago
argenx to acquire Unnatural Products for up to $1.15B, expanding peptide drug discovery in immunology

argenx to acquire Unnatural Products for up to $1.15B, expanding peptide drug discovery in immunology

argenx announced it will acquire Unnatural Products, Inc. (UNP) for up to $1.15 billion, including upfront and milestone payments. This acquisition adds UNP's macrocyclic peptide discovery platform to argenx's antibody engineering capabilities, broad...

Company Fundamentals
Bullish
5 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App